CRIS Current Research Information System

PAROLIN, CAROLA ELEONORA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 9.499
NA - Nord America 8.917
EU - Europa 7.892
AF - Africa 675
SA - Sud America 435
OC - Oceania 29
Continente sconosciuto - Info sul continente non disponibili 4
Totale 27.451
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.775
IT - Italia 2.784
SG - Singapore 2.536
CN - Cina 2.456
VN - Vietnam 2.290
GB - Regno Unito 1.482
DE - Germania 839
HK - Hong Kong 705
SE - Svezia 624
IN - India 463
FR - Francia 453
RU - Federazione Russa 326
BR - Brasile 312
NL - Olanda 306
IE - Irlanda 221
UA - Ucraina 219
KR - Corea 205
ZA - Sudafrica 169
CI - Costa d'Avorio 158
PK - Pakistan 153
JP - Giappone 149
FI - Finlandia 122
TG - Togo 109
SC - Seychelles 98
CA - Canada 81
PL - Polonia 71
ID - Indonesia 70
EE - Estonia 68
AR - Argentina 65
BE - Belgio 58
CH - Svizzera 57
PH - Filippine 54
TH - Thailandia 54
NG - Nigeria 52
JO - Giordania 48
TR - Turchia 45
BG - Bulgaria 44
BD - Bangladesh 43
ES - Italia 42
TW - Taiwan 39
AT - Austria 38
IQ - Iraq 37
IR - Iran 34
GR - Grecia 33
MX - Messico 33
AU - Australia 24
HR - Croazia 23
MY - Malesia 22
EG - Egitto 20
CL - Cile 17
LT - Lituania 16
SA - Arabia Saudita 16
UZ - Uzbekistan 16
DZ - Algeria 14
MA - Marocco 14
RO - Romania 14
LB - Libano 13
EC - Ecuador 10
AE - Emirati Arabi Uniti 9
DK - Danimarca 9
CZ - Repubblica Ceca 8
KE - Kenya 8
VE - Venezuela 8
AL - Albania 7
CO - Colombia 7
BB - Barbados 6
GH - Ghana 6
PE - Perù 6
PT - Portogallo 6
TN - Tunisia 6
UY - Uruguay 6
ET - Etiopia 5
HU - Ungheria 5
KZ - Kazakistan 5
NZ - Nuova Zelanda 5
SN - Senegal 5
IL - Israele 4
NP - Nepal 4
QA - Qatar 4
BZ - Belize 3
DO - Repubblica Dominicana 3
NO - Norvegia 3
OM - Oman 3
PA - Panama 3
PY - Paraguay 3
AM - Armenia 2
AZ - Azerbaigian 2
BH - Bahrain 2
BW - Botswana 2
GE - Georgia 2
GT - Guatemala 2
JM - Giamaica 2
KG - Kirghizistan 2
KH - Cambogia 2
MK - Macedonia 2
MM - Myanmar 2
MT - Malta 2
NI - Nicaragua 2
PS - Palestinian Territory 2
RS - Serbia 2
Totale 27.416
Salva come PNG Salva come JPEG
Città #
Singapore 1.789
Ashburn 1.408
Southend 1.242
Chandler 700
Hong Kong 643
Bologna 584
San Jose 542
Ho Chi Minh City 464
Santa Clara 433
Fairfield 432
Hanoi 377
Dong Ket 369
Hefei 366
Ann Arbor 335
Beijing 294
Princeton 262
Houston 247
Wilmington 236
Seattle 235
Boardman 217
Woodbridge 216
Dublin 215
Los Angeles 202
Cambridge 180
Frankfurt am Main 172
Seoul 166
Abidjan 158
Dallas 148
Lauterbourg 143
New York 141
Milan 140
Padova 122
Nanjing 115
Westminster 115
Lomé 109
Council Bluffs 105
Tokyo 103
Berlin 98
Helsinki 91
Jacksonville 91
Rome 87
Redmond 84
Jinan 82
Turin 80
Medford 78
Modena 76
Buffalo 72
Guangzhou 71
Lahore 71
Cesena 70
Shanghai 66
Da Nang 63
Munich 62
Saint Petersburg 62
Shenyang 60
Dearborn 56
Naples 55
Johannesburg 54
Abeokuta 48
Amman 48
Changsha 48
Florence 48
Gujranwala 48
Haiphong 48
Bengaluru 47
Nanchang 45
Tianjin 45
Redondo Beach 44
Hebei 43
Sofia 43
São Paulo 43
The Dalles 42
Brussels 41
San Diego 41
Amsterdam 39
Jakarta 39
Warsaw 35
London 34
Toronto 33
Tukwila 32
Chicago 31
Orem 31
Redwood City 31
Des Moines 29
Phoenix 29
Basingstoke 27
Falls Church 27
Shenzhen 27
Forlì 26
Hangzhou 26
Pune 26
Zhengzhou 26
Bern 25
Brooklyn 24
Ancona 23
Biên Hòa 23
Montreal 23
Nuremberg 22
Bangkok 21
Jiaxing 21
Totale 16.706
Salva come PNG Salva come JPEG
Nome #
Accuratezza della spettrometria di massa MALDI-TOF nell’identificazione di specie di lattobacilli 714
Mechanism and stereoselectivity of HDAC I inhibition by (R)-9-hydroxystearic acid in colon cancer. 537
NUOVI APPROCCI PER L’IDENTIFICAZIONE DI SPECIE DI LATTOBACILLI: RUOLO DELLA SPETTROMETRIA DI MASSA MALDI-TOF E DELLA METABOLOMICA 484
BIFIDOBACTERIUM BREVE BC104: ORALLY ADMINISTERED VAGINAL PROBIOTIC FOR PREVENTING GENITAL AND URINARY TRACT INFECTIONS 338
MICROBIOTA VAGINALE IN CORSO DI INFEZIONI DEL TRATTO GENITALE 326
Lactobacillus crispatus inhibits the infectivity of Chlamydia trachomatis elementary bodies, in vitro study 291
Isolation of vaginal lactobacilli and characterization of anti-candida activity 289
Lactobacillus crispatus BC5 Interferes With Chlamydia trachomatis Infectivity Through Integrin Modulation in Cervical Cells. 284
Insights Into Vaginal Bacterial Communities and Metabolic Profiles of Chlamydia trachomatis Infection: Positioning Between Eubiosis and Dysbiosis 281
Impact of fermented soy beverages containing selected vaginal probiotics on the in vitro fecal microbiota of post-menopausal women 267
A peptidic hydrogel that may behave as a "trojan Horse" 252
Genotypic and phenotypic characterization of Lactobacillus strains with antipathogenic activities 247
Development and characterization of fermented soy beverages containing encapsulated or non-encapsulated vaginal probiotics 241
Biosurfactant from vaginal Lactobacillus crispatus BC1 as a promising agent to interfere with Candida adhesion 239
Development of a Fermented Milk Designed for Women's Well-Being Containing an Exopolysaccharides-Producing Starter Culture and a Functional Vaginal Strain 237
Azithromycin-loaded liposomes and niosomes for the treatment of skin infections: influence of excipients and preparative methods on the functional properties 230
A NEW EPIDERMAL GROWTH FACTOR RECEPTOR INHIBITOR IN COLON CANCER CELLS 227
Determination of antibacterial and technological properties of vaginal lactobacilli for their potential application in dairy products 222
Design and validation of a DNA-microarray for phylogenetic analysis of bacterial communities in different oral samples and dental implants 221
Diversity of vaginal microbiome and metabolome during genital infections 221
ANTITUMOR ACTIVITY OF INDOLE-DERIVATIVES IN THE HUMAN OVARIAN CANCER CELL LINE IGROV-1 218
ANTIPROLIFERATIVE ACTIVITY OF ENANTIOMERICALLY PURE (R) AND (S)-9-HYDROXYSTEARIC ACID IN HT29 COLON CANCER CELLS. 217
Vaginal Lactobacilli Supernatants Protect from Herpes Simplex Virus Type 1 Infection in Cell Culture Models 216
Development of azithromycin-loaded microemulsions for the treatment of skin infections 216
A new EGFR inhibitor induces apoptosis in colon cancer cells. 216
ANTITUMOR ACTIVITY OF NEW SUBSTITUTED 3-(5- IMIDAZO[2,1-b]THIAZOLYLMETHYLENE)-2-INDOLINONES 211
VAGINAL MICROBIOME FOR THE PRESERVATION OF WOMEN’S HEALTH USING FOOD STRATEGY 210
Liposomes containing biosurfactants isolated from Lactobacillus gasseri exert antibiofilm activity against methicillin resistant Staphylococcus aureus strains 208
Anti-bacterial activity of vaginal lactobacilli against Chlamydia trachomatis 207
Biosurfactant for solubilization and skin permeation enhancement of hydrocortisone 207
Exopolysaccharides from vaginal lactobacilli modulate microbial biofilms 206
9-Hydroxystearic acid and sulforaphane: two natural HDAC inhibitors with distinct effects on HT29 cells. 206
Computer vision approach for the determination of microbial concentration and growth kinetics using a low cost sensor system 206
Lactobacilli extracellular vesicles: potential postbiotics to support the vaginal microbiota homeostasis 205
Anti-bacterial activity of 17 strains of lactobacilli against elementary bodies of Chlamydia trachomatis 205
(R)-9-HSA HAS A MORE REMARKABLE ANTIPROLIFERATIVE EFFECT COMPARE TO (S)-9-HSA. 201
Anti-bacterial activity of 17 strains of lactobacilli against elementary bodies of Chlamydia trachomatis 199
Novel approaches for the taxonomic and metabolic characterization of lactobacilli: Integration of 16S rRNA gene sequencing with MALDI-TOF MS and 1H-NMR 198
Analysis of human histone H4 by capillary electrophoresis in a pullulan-coated capillary, LC-ESI-MS and MALDI-TOF-MS 198
Novel mixed vesicles containing lactobacilli biosurfactants for vaginal delivery of econazole nitrate 197
OralArray: a new phylogenetic DNA-microarray to characterize the oral microbiota 195
9-Hydroxystearic acid interferes with EGF signalling in a human colon adenocarcinoma 194
Insight into phenotypic and genotypic differences between vaginal Lactobacillus crispatus BC5 and Lactobacillus gasseri BC12 to unravel nutritional and stress factors influencing their metabolic activity 192
Bacterial concentration detection using a portable embedded sensor system for environmental monitoring 190
9-HSA INDUCES APOPTOSIS AND INCREASES SENSITIVITY TO IMATINIB IN IMATINIB RESISTANT COLON CANCER CELLS 190
A NEW EPIDERMAL GROWTH FACTOR RECEPTOR INHIBITOR IN COLON CANCER CELLS 190
Azithromycin-loaded vesicles for the treatment of skin infections: a comparative study of different formulations 188
Vaginal Lactobacillus strains interfere with Chlamydia trachomatis infection 186
Development and Characterization of Azithromycin-Loaded Microemulsions: A Promising Tool for the Treatment of Bacterial Skin Infections 182
9-HSA INDUCES APOPTOSIS AND INCREASES SENSITIVITY TO IMATINIB IN IMATINIB RESISTANT COLON CANCER CELLS 181
Vaginal Lactobacillus Impair Candida Dimorphic Switching and Biofilm Formation 179
In-vitro effect of vaginal lactobacilli against group B Streptococcus 177
Use of Lactobacillus crispatus to produce a probiotic cheese as potential gender food for preventing gynaecological infections 177
Unpredictable Dynamic Behaviour of Ruthenium Chelate Pyrrole Derivatives 176
Vaginal microbiome and metabolome highlight specific signatures of bacterial vaginosis 173
Vaginal Lactobacillus gasseri biosurfactant: a novel bio- and eco-compatible anti-Candida agent 171
Protective Mechanisms of Vaginal Lactobacilli against Sexually Transmitted Viral Infections 167
Limosilactobacillus vaginalis Exerts Bifidogenic Effects: A Novel Postbiotic Strategy for Infant Prebiotic Supplementation 166
Human Breast Milk: A Source of Potential Probiotic Candidates 166
Approcci innovativi per l’identificazione di specie di lattobacilli: studio dei metaboliti mediante spettrometria di risonanza magnetica (1H-RMN) 165
Electrical Impedance Spectroscopy (EIS) characterization of saline solutions with a low-cost portable measurement system 165
NUCLEAR REDISTRIBUTION OF EXOGENOUS ADMINISTERED 9- AND 10-HSA, ANALYZED BY MASS SPECTROMETRY 164
Cell cycle arrest induced by sulforaphane in human colon carcinoma cells HT29 is associated with the hyperacetylation of histone H4. 163
Isolation and characterization of biosurfactants produced by Lactobacillus gasseri of vaginal origin 163
Metabolic profiling of Candida clinical isolates of different species and infection sources 163
Biosurfactant loaded vesicles for the local treatment of Staphylococcus aureus skin infections 163
Redox Signaling via Lipid Peroxidation Regulates Retinal Progenitor Cell Differentiation. 163
Efficacy and Safety of a Multistrain Probiotic Formulation Depends from Manufacturing 160
BIOLOGICAL EFFECTS OF A NEW CLASS I HDAC SELECTIVE INHIBITOR IN HT29 COLON CANCER CELLS. 159
Evaluation of the fate of Lactobacillus crispatus BC4, carried in Squacquerone cheese, throughout the simulator of the human intestinal microbial ecosystem (SHIME) 158
IDENTIFICATION OF HISTONE MODIFICATIONS INVOLVED IN HDAC1 INHIBITION BY 9-HSA 157
Mucoadhesive Buccal Films for Local Delivery of Lactobacillus brevis 157
Anti-candida activity of hyaluronic acid combined with lactobacillus crispatus lyophilised supernatant: A new antifungal strategy 157
null 156
Modulation of apoptotic signalling by 9-hydroxystearic acid in osteosarcoma cells 156
Vaginal Lactobacilli Reduce Neisseria gonorrhoeae Viability through Multiple Strategies: An in Vitro Study. 156
Orange Peel Lactiplantibacillus plantarum: Development of A Mucoadhesive Nasal Spray with Antimicrobial and Anti-Inflammatory Activity 155
Designing fermented milk with targeted probiotics: a step toward female-focused functional foods 154
Lactobacillus crispatus interferes with Chlamydia trachomatis infectivity through modulation of integrin exposure in cervical cells 154
Extracellular vesicles from symbiotic vaginal lactobacilli inhibit HIV-1 infection of human tissues 154
CYTOTOXICITY EVALUATION OF A POLYAMINE-QUINONE LIBRARY CONJUGATES IN HUMAN COLON CARCINOMA CELLS 152
Vaginal microbiome signatures in Chlamydia trachomatis infected women 151
Vaginal Bifidobacterium breve for preventing urogenital infections: Development of delayed release mucoadhesive oral tablets 151
Probiotic and metabolic characterization of vaginal lactobacilli for a potential use in functional foods 151
Lactobacillus crispatus to produce a functional cheese as dietary strategy to improve woman wellbeing 150
Histone post-translational modifications by HPLC-ESI-MS after HT29 cell treatment with histone deacetylase inhibitors 148
A portable sensor system for bacterial concentration monitoring in metalworking fluids 148
THE INDOLE-DERIVATIVE 3L INTERFERES WITH ESTROGEN RECEPTOR SIGNALLING IN IGROV 1 OVARIAN CANCER CELLS 145
Histone proteins determined in a human colon cancer by high-performance liquid chromatography and mass spectrometry 144
Development and validation of a new phylogenetic DNA-microarray specific for the oral microbiota 144
Lactobacillus crispatus BC1 Biosurfactant Delivered by Hyalurosomes: An Advanced Strategy to Counteract Candida Biofilm 144
Freeze-Dried Matrices Based on Polyanion Polymers for Chlorhexidine Local Release in the Buccal and Vaginal Cavities 143
Interaction of vaginal Lactobacillus strains with HeLa cell plasma membrane. 142
The cell cycle arrest induced by sulforaphane in human colon carcinoma cells HT29 is associated with the hyperacetylation of histone H4. 141
THE HEALTH-PROMOTING EFFECT OF EXTRACELLULAR VESICLES RELEASED BY VAGINAL LACTOBACILLI 140
HISTONE POST-TRANSLATIONAL MODIFICATIONS BY HPLC-ESI-MS AFTER HT29 CELL TREATMENT WITH HDACS INHIBITORS. 140
Antiproliferative activity of enantiomerically pure (R)-9-hydroxystearic acid in HT29 colon cancer cells. 140
CYTOSTATIC AND CYTOTOXIC EFFECTS OF A NEW SYNTHESIZED GUANYLHYDRAZONE DERIVATIVES IN HUMAN LEUKEMIC CELL LINE HL-60 139
Metabolic Variability of a Multispecies Probiotic Preparation Impacts on the Anti-inflammatory Activity 139
Association of Lactobacillus crispatus with fructo-oligosaccharides and ascorbic acid in hydroxypropyl methylcellulose vaginal insert 139
Totale 19.968
Salva come PNG Salva come JPEG
Categoria #
all - tutte 68.145
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 68.145
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021986 0 0 0 0 0 0 0 0 0 130 107 749
2021/20222.631 315 126 149 110 231 154 92 170 103 193 511 477
2022/20233.178 310 450 193 401 230 241 85 174 497 186 217 194
2023/20241.941 107 168 103 138 162 374 209 353 56 94 108 69
2024/20254.673 230 503 448 361 680 261 431 229 131 334 296 769
2025/20269.739 893 990 843 754 1.086 612 1.364 451 1.926 820 0 0
Totale 28.077